Your browser doesn't support javascript.
loading
PD-1 blockade with nivolumab in endemic Kaposi sarcoma.
Delyon, J; Bizot, A; Battistella, M; Madelaine, I; Vercellino, L; Lebbé, C.
Afiliação
  • Delyon J; Dermatology Department, AP-HP Hôpital Saint Louis, Paris, France; Université Paris VII Diderot, Sorbonne Paris Cité, Paris, France; INSERM U976, Paris, France. Electronic address: julie.delyon@aphp.fr.
  • Bizot A; Dermatology Department, AP-HP Hôpital Saint Louis, Paris, France.
  • Battistella M; Université Paris VII Diderot, Sorbonne Paris Cité, Paris, France; Pathology Department, AP-HP Hôpital Saint Louis, Paris, France; INSERM U1165, AP-HP Hôpital Saint Louis, Paris, France.
  • Madelaine I; Department of Pharmacy, AP-HP Hôpital Saint Louis, Paris, France.
  • Vercellino L; Department of Nuclear Medicine, AP-HP Hôpital Saint Louis, Paris, France.
  • Lebbé C; Dermatology Department, AP-HP Hôpital Saint Louis, Paris, France; Université Paris VII Diderot, Sorbonne Paris Cité, Paris, France; INSERM U976, Paris, France.
Ann Oncol ; 29(4): 1067-1069, 2018 04 01.
Article em En | MEDLINE | ID: mdl-29324995
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma de Kaposi / Receptor de Morte Celular Programada 1 / Nivolumabe Limite: Aged / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma de Kaposi / Receptor de Morte Celular Programada 1 / Nivolumabe Limite: Aged / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article